BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9109439)

  • 1. Gene rearrangement: a novel mechanism for MDR-1 gene activation.
    Mickley LA; Spengler BA; Knutsen TA; Biedler JL; Fojo T
    J Clin Invest; 1997 Apr; 99(8):1947-57. PubMed ID: 9109439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL.
    Knutsen T; Mickley LA; Ried T; Green ED; du Manoir S; Schröck E; Macville M; Ning Y; Robey R; Polymeropoulos M; Torres R; Fojo T
    Genes Chromosomes Cancer; 1998 Sep; 23(1):44-54. PubMed ID: 9713996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines.
    Knutsen T; Rao VK; Ried T; Mickley L; Schneider E; Miyake K; Ghadimi BM; Padilla-Nash H; Pack S; Greenberger L; Cowan K; Dean M; Fojo T; Bates S
    Genes Chromosomes Cancer; 2000 Jan; 27(1):110-6. PubMed ID: 10564593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance induced by ouabain via the stimulation of MDR1 gene expression in human carcinomatous pulmonary cells.
    Brouillard F; Tondelier D; Edelman A; Baudouin-Legros M
    Cancer Res; 2001 Feb; 61(4):1693-8. PubMed ID: 11245485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia.
    Mikhail FM; Coignet L; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Farahat N; Nucifora G
    Genes Chromosomes Cancer; 2004 Feb; 39(2):110-8. PubMed ID: 14695990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y; Qian F; Wei D; Liu J
    J Pharm Pharmacol; 2004 Oct; 56(10):1307-14. PubMed ID: 15482646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TEL/AML1 overcomes drug resistance through transcriptional repression of multidrug resistance-1 gene expression.
    Asakura K; Uchida H; Miyachi H; Kobayashi H; Miyakawa Y; Nimer SD; Takahashi H; Ikeda Y; Kizaki M
    Mol Cancer Res; 2004 Jun; 2(6):339-47. PubMed ID: 15235109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells.
    Chano T; Mori K; Scotlandi K; Benini S; Lapucci C; Manara MC; Serra M; Picci P; Okabe H; Baldini N
    Oncol Rep; 2004 Jun; 11(6):1257-63. PubMed ID: 15138564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of P-glycoprotein expression in multidrug-resistant tumor cells by a designed transcriptional regulator.
    Xu D; Ye D; Fisher M; Juliano RL
    J Pharmacol Exp Ther; 2002 Sep; 302(3):963-71. PubMed ID: 12183653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdissected double-minute DNA detects variable patterns of chromosomal localizations and multiple abundantly expressed transcripts in normal and leukemic cells.
    Sen S; Sen P; Mulac-Jericevic B; Zhou H; Pirrotta V; Stass SA
    Genomics; 1994 Feb; 19(3):542-51. PubMed ID: 8188297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of the ABCB1 region accompanied by a short sequence of 200bp from chromosome 2 in lung cancer cells.
    Kitada K; Yamasaki T; Aikawa S
    Cancer Genet Cytogenet; 2009 Oct; 194(1):4-11. PubMed ID: 19737648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential changes in genome structure and expression of the mdr gene family in multidrug-resistant murine erythroleukemia cell lines.
    Fracasso PM; Slapak CA; Nair S; Modrak D; Draper MP; LeCerf JM; Levy SB
    Oncol Res; 1997; 9(4):183-91. PubMed ID: 9268989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
    Xu D; Lu Q; Hu X
    Cancer Lett; 2006 Nov; 243(2):274-80. PubMed ID: 16406853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cytogenetic characterization of doxorubicin-resistant neuroblastoma cell lines: evidence that acquired multidrug resistance results from a unique large amplification of the 7q21 region.
    Flahaut M; Mühlethaler-Mottet A; Martinet D; Fattet S; Bourloud KB; Auderset K; Meier R; Schmutz NB; Delattre O; Joseph JM; Gross N
    Genes Chromosomes Cancer; 2006 May; 45(5):495-508. PubMed ID: 16450357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The isolation and genetic characteristics of the new cell line of mouse myeloma spEBR-5 selected for ethidium bromide resistance and characterized by multiple drug resistance].
    Berezkina EV; Lipskaia LA; Grinchuk TM; Kovaleva ZV; Sorokina EA; Vasiukhin VI; Ignatova TN
    Tsitologiia; 1994; 36(7):687-95. PubMed ID: 7900209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular features of a new human lymphoma cell line carrying both BCL2 and BCL6 gene rearrangements.
    Yonetani N; Akasaka T; Akasaka H; Ohno H; Okuma M; Miura I; Takahashi N; Miyanishi S; Okumura A; Muramatsu M; Fukuhara S
    Oncogene; 1998 Aug; 17(8):971-9. PubMed ID: 9747876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
    Günthert AR; Gründker C; Bongertz T; Schlott T; Nagy A; Schally AV; Emons G
    Am J Obstet Gynecol; 2004 Oct; 191(4):1164-72. PubMed ID: 15507937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.